Oral GLP-1 Wegovy chases approval in obesity May 5, 2025 By Lee Landenberger No Comments The U.S
If you receive weekly semaglutide injections, ensure your last dose was given at least 24 hours before your procedure
By 2024, an estimated 12% of American adults reported taking a GLP-1 medication for diabetes, weight loss, or heart disease, according to data from the Kaiser Family Foundation
Common Adverse Effects of GLP-1-Based Therapies Gastrointestinal (GI) Side Effects Gastrointestinal discomfort is the most frequently reported side effect of GLP-1-based therapies, including single, dual, and triple agonists
Depo-Provera, a contraceptive injection, has been linked to an increased risk of developing brain tumors (including glioblastoma and meningioma)
Adding extra protein transforms soup into complete meal